Novavax News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

14.11.22	Novavax to Participate in Jefferies London Healthcare Conference (PR Newswire)
09.11.22	Novavax's Nuvaxovid COVID-19 Vaccine Authorized In U.K. For Use As Booster In Adults (RTTNews)
09.11.22	Novavax Nuvaxovid™ COVID-19 Vaccine▼ Authorized in the United Kingdom for Use as a Booster in Adults (PR Newswire)
08.11.22	Novavax Inc. Q3 Loss decreases, but misses estimates (RTTNews)
08.11.22	Novavax Reports Third Quarter 2022 Financial Results and Operational Highlights (PR Newswire)
08.11.22	Novavax BA.1 Vaccine Candidate Meets Primary Strain-change Endpoint (RTTNews)
08.11.22	Novavax Phase 3 COVID-19 Omicron Trial Supports the Continued and Future Use of Novavax Prototype Vaccine as a Booster (PR Newswire)
01.11.22	Novavax Appoints Rick Rodgers to Board of Directors (PR Newswire)
01.11.22	Novavax to Host Conference Call to Discuss Third Quarter 2022 Financial Results and Operational Highlights on November 8, 2022 (PR Newswire)
20.10.22	Novavax Showcases Data from Expanding Vaccine Portfolio at IDWeek 2022 (PR Newswire)
19.10.22	FDA Grants EUA For Novavax COVID-19 Vaccine, Adjuvanted As A Booster For Adults (RTTNews)
19.10.22	U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults (PR Newswire)
13.10.22	Novavax's CIC Vaccine Candidate Induces Antibody, T-Cell Responses Against SARS-CoV-2 (RTTNews)
13.10.22	Novavax COVID-19-Influenza Combination Vaccine Candidate Induced Antibody and T-Cell Responses Against SARS-CoV-2 and Homologous and Heterologous Influenza Strains (PR Newswire)
12.10.22	Novavax: Prototype NVX-CoV2373 Achieves Pre-specified Immunologic Endpoint In PREVENT-19 Trial (RTTNews)
12.10.22	Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants (PR Newswire)
10.10.22	Novavax to Share New Data from Growing Vaccine Portfolio at World Vaccine Congress Europe 2022 (PR Newswire)
27.09.22	Novavax Says One Mln Doses Of Nuvaxovid Ready For Use In UK To Fight Covid-19 (RTTNews)
27.09.22	Novavax Makes One Million Doses of Nuvaxovid™ Available for Use in the United Kingdom (PR Newswire)
16.09.22	Novavax's Nuvaxovid COVID-19 Vaccine Gets Expanded EUA In Taiwan For Use In Adolescents (RTTNews)
16.09.22	Novavax's Says Nuvaxovid COVID-19 Vaccine Now Available In Israel For Individuals Aged 12 And Older (RTTNews)
16.09.22	Novavax Nuvaxovid™ COVID-19 Vaccine Receives Expanded Emergency Use Authorization in Taiwan for Use in Adolescents Aged 12 Through 17 (PR Newswire)
16.09.22	Novavax Nuvaxovid™ COVID-19 Vaccine Now Available in Israel for Individuals Aged 12 and Older (PR Newswire)
13.09.22	Novavax Reports Full Product Registration In South Africa Of Novavax COVID-19 Vaccine (RTTNews)
13.09.22	Novavax and Serum Institute of India Announce Full Product Registration in South Africa of Novavax COVID-19 Vaccine as a Primary Series for Adults Aged 18 and Older (PR Newswire)
12.09.22	Novavax Says Nuvaxovid Covid-19 Vaccine Gets Expanded CMA In EU As Booster; Stock Up (RTTNews)
12.09.22	Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization in the European Union for Use as a Booster for Adults Aged 18 and Older (PR Newswire)
07.09.22	Novavax to Participate in Upcoming September Conferences (PR Newswire)
03.09.22	Swissmedic Authorizes Novavax COVID-19 Vaccine For Adolescents And As Booster In Adults (RTTNews)
02.09.22	Swissmedic Authorizes Novavax Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12 Through 17 and as a Booster in Adults Aged 18 and Older (PR Newswire)
02.09.22	Novavax : CHMP Recommends Approval Of Its COVID-19 Booster Vaccine (RTTNews)
01.09.22	Novavax Nuvaxovid™ COVID-19 Vaccine Recommended by CHMP for Expanded Conditional Marketing Authorization in the European Union as a Booster for Adults Aged 18 and Older (PR Newswire)
26.08.22	Novavax's COVID-19 Vaccine Granted Expanded Conditional Authorization In U.K. For Adolescents (RTTNews)
26.08.22	Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization in the United Kingdom for Use in Adolescents Aged 12 Through 17 (PR Newswire)
20.08.22	Novavax COVID-19 Vaccine, Adjuvanted Gets Expanded EUA Approval From U.S. FDA For Adolescents (RTTNews)
20.08.22	U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Adolescents Aged 12 Through 17 (PR Newswire)
18.08.22	Novavax: COVID-19 Vaccine Granted Expanded Provisional Approval In New Zealand For Adolescents (RTTNews)
18.08.22	Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand for Adolescents Aged 12 Through 17 (PR Newswire)
17.08.22	New Zealand Grants Expanded Approval For Novavax's Nuvaxovid COVID-19 Vaccine As Booster For Adults (RTTNews)
17.08.22	Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a First and Second Booster for Adults (PR Newswire)
15.08.22	Novavax Submits EUA Application To FDA For COVID-19 Booster In Adults (RTTNews)
15.08.22	Novavax Submits Application to the U.S. FDA for Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster in Adults Aged 18 and Older (PR Newswire)
12.08.22	South Korea Approves Novavax's Nuvaxovid COVID-19 Vaccine For Use In Adolescents (RTTNews)
12.08.22	Novavax Nuvaxovid™ COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17 (PR Newswire)
11.08.22	Novavax to Participate in Fireside Chat at the SVB Securities Virtual Vaccine Forum (PR Newswire)
09.08.22	Pre-market Movers: CRMD, GDRX, QBTS, NVAX, VRNA… (RTTNews)
08.08.22	Novavax Lowers FY22 Revenue Outlook (RTTNews)
08.08.22	Novavax Inc. Q2 Loss increases, misses estimates (RTTNews)
08.08.22	Novavax Reports Second Quarter 2022 Financial Results and Operational Highlights (PR Newswire)
04.08.22	Novavax Announces Initiation of Phase 2b/3 Hummingbird™ Global Clinical Trial for the Novavax COVID-19 Vaccine in Children Aged Six Months Through 11 Years (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

07:45		Novartis-Aktie: EU-Zulassung für Kisqali bei Brustkrebs im Frühstadium
26.11.24		Zuversicht in New York: Zum Handelsende Gewinne im NASDAQ 100
26.11.24		Dow Jones aktuell: Dow Jones zum Handelsende in Grün
26.11.24		Börse New York: Dow Jones wenig verändert
26.11.24		Starker Wochentag in New York: NASDAQ 100-Anleger greifen am Nachmittag zu
26.11.24		Optimismus in New York: NASDAQ 100 mittags freundlich
26.11.24		Verluste in New York: Dow Jones legt den Rückwärtsgang ein
26.11.24		Schwache Performance in Europa: Euro STOXX 50 schlussendlich leichter

07:45

Novartis-Aktie: EU-Zulassung für Kisqali bei Brustkrebs im Frühstadium

26.11.24

Zuversicht in New York: Zum Handelsende Gewinne im NASDAQ 100

26.11.24

Dow Jones aktuell: Dow Jones zum Handelsende in Grün

26.11.24

Börse New York: Dow Jones wenig verändert

26.11.24

Starker Wochentag in New York: NASDAQ 100-Anleger greifen am Nachmittag zu

26.11.24

Optimismus in New York: NASDAQ 100 mittags freundlich